Bispecific Anti-CD37 antibodies, monoclonal Anti-CD37 antibodies and methods of use thereof

NZ798803BActive Publication Date: 2026-09-29GENMAB AS
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
NZ798803
Authority / Receiving Office
NZ · NZ
Patent Type
Patents
Current Assignee / Owner
Priority Date
2018-03-27
Filing Date
2018-04-03
Publication Date
2026-09-29
Estimated Expiration
2038-04-03

Smart Images

  • Figure 00000115_0000
    Figure 00000115_0000
  • Figure 00000115_0001
    Figure 00000115_0001
  • Figure 00000116_0000
    Figure 00000116_0000
Patent Text Reader

Abstract

CD37-specific bispecific antibody molecules binding to different epitopes of the human CD37 antigen which bispecific antibody molecules have enhanced Fc-Fc interactions upon binding to CD37 on the cell surface. The invention also relates to the monoclonal parental antibodies from which the first or the second binding region of the bispecific antibody molecules is obtained. The invention also relates to pharmaceutical compositions containing these molecules and the treatment of cancer and other diseases using these compositions.
Need to check novelty before this filing date? Find Prior Art